Vacirca Jeff L's Form 4 filing
Caris Life Sciences, Inc. (CAI) · filed May 12, 2026
- Accession no.
- 0001724161-26-000005
- Filed
- May 12, 2026
- Trade date
- May 11, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $501.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vacirca Jeff LCIK 0001724161 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | PPurchaseAcquired | +31,050 | $16.15 | +$501,457.5 | 49,671 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.